Results 231 to 240 of about 148,322 (271)

Quality of life and healthcare resource utilization among adult patients with short bowel syndrome: A mixed‐methods study leveraging an integrated database

Nutrition in Clinical Practice, EarlyView.
Abstract Background Short bowel syndrome (SBS) is a chronic condition requiring parenteral nutrition (PN) support and multidisciplinary management. However, disparities in access to care and standardized treatment pathways, in addition to economic burden, remain considerable for patients.
Deborah Kuk, Brian Po‐Han Chen, Megan Gower, Michelle Kirby, Brian Terreri, Josh Feldman, Maggie McCue, Manpreet S. Mundi   +7 more
wiley   +1 more source

Telepharmacy for Chronic Disease Management in Saudi Arabia Compared With the United States and the United Kingdom: A Narrative Review. [PDF]

Cureus
Alali A, Nasser F, Bin Rakan M, Alrasheed MA.   +3 more
europepmc   +1 more source

Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study

Nutrition in Clinical Practice, EarlyView.
Abstract Background Pancreatic enzyme insufficiency (PEI) contributes to symptom burden and malnutrition in advanced pancreatic cancer (aPC). We aimed to evaluate the impact of pancreatic enzyme replacement therapy (PERT) on symptom burden and weight during chemotherapy.
Pamela N. Klassen, Christina A. Kim, Jessica Kasnik, Michael B. Sawyer, Sunita Ghosh, Vickie Baracos, Vera C. Mazurak   +6 more
wiley   +1 more source

Clinical application and institutional governance of foods for special medical purposes in medical institutions of eastern coastal China: a cross-sectional study. [PDF]

Front Nutr
Deng Q, Pu W, Zhu T, Yang J, Chen J, Chen X, Zhao Q, Xu Y, Wang SA, Chen F, Chen X.   +10 more
europepmc   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

"If I am here, it is because the system failed": a critical qualitative study of global commercial clinical trials for advanced cancer in Chile. [PDF]

Global Health
Fernández-González L, Rodin G, Sapunar J, Perez-Brumer A, Birn AE.   +4 more
europepmc   +1 more source

Des Moines Independent Community School District, No. 77-1737 and Des Moines Education Association (1991) [PDF]

, 1991

core   +1 more source

Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications

Obesity, EarlyView.
ABSTRACT Objective Antiobesity medications (AOMs) are indicated for long‐term use; however, evidence of their real‐world long‐term efficacy is limited. This study describes clinical outcomes from 18‐ and 24‐month use of AOMs in a telemedicine weight management clinic.
Kathleen R. Ruddiman, Young‐Rock Hong, Jamy Ard, Rebecca Jones, Adam Medcalf, Gary D. Foster, Jamil Alkhaddo, Michelle Cardel   +7 more
wiley   +1 more source

Health system barriers to cardiovascular disease prevention and control in Iran: a qualitative study. [PDF]

BMC Health Serv Res
Mansouri A, Amini-Rarani M, Bahrani S, Jozan M, Babadi ME, Hoseinkhani R, Khosravi A, Ahmadi H, Bagherikholenjani F.   +8 more
europepmc   +1 more source

Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment

Obesity, EarlyView.
ABSTRACT Objective We sought to determine how the proportion of adults historically receiving obesity interventions would be classified under the recently proposed “pre‐clinical” and “clinical” obesity classifications and the impact of this change on safety and outcomes.
Jason M. Samuels, Emma Holler, Matthew D. Spann, C. Joe Northup, Tarik K. Yuce   +4 more
wiley   +1 more source